SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

Citigroup Downgrades MyoKardia to Neutral, Raises Price Target to $225

Citigroup analyst Mohit Bansal downgrades MyoKardia (NASDAQ:MYOK) from Buy to Neutral and raises the price target from $125 to $225.

· 10/06/2020 06:15
Citigroup analyst Mohit Bansal downgrades MyoKardia (NASDAQ:MYOK) from Buy to Neutral and raises the price target from $125 to $225.